Tuesday, March 5, 2024

🌎 AT&T Upgraded, SEA Upgraded, Lyft Upgraded and more...

Ratings changes for CrowdStrike, Jaguar Health, bluebird bio, Cassava Sciences, DraftKings, Exelon, ARS Pharmaceuticals and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
March 5th, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 


Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • BARK (NYSE:BARK) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $1.90 price target on the stock, up previously from $1.54. This represents a 46.7% upside from the current price of $1.30.
  • Cable One (NYSE:CABO) was upgraded by analysts at Moffett Nathanson from a "neutral" rating to a "buy" rating. They now have a $615.00 price target on the stock. This represents a 34.8% upside from the current price of $456.29.
  • Lyft (NASDAQ:LYFT) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock. This represents a 20.3% upside from the current price of $16.63.
  • ONE Gas (NYSE:OGS) was upgraded by analysts at LADENBURG THALM/SH SH from a "neutral" rating to a "buy" rating. They now have a $64.50 price target on the stock. This represents a 3.7% upside from the current price of $62.18.
  • SEA (NYSE:SE) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $70.00 price target on the stock, up previously from $43.00. This represents a 28.4% upside from the current price of $54.50.
  • ARS Pharmaceuticals (NASDAQ:SPRY) was upgraded by analysts at SVB Leerink LLC from a "market perform" rating to an "outperform" rating. They now have a $18.00 price target on the stock, up previously from $6.00. This represents a 100.2% upside from the current price of $8.99.
  • AT&T (NYSE:T) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $21.00 price target on the stock. This represents a 21.5% upside from the current price of $17.28.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades
  • Floor & Decor (NYSE:FND) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $135.00 price target on the stock. This represents a 11.3% upside from the current price of $121.25.
  • Samsung Electronics (OTCMKTS:SSNLF) was downgraded by analysts at Susquehanna from a "positive" rating to a "neutral" rating.The current price is $40.60.
  • View today's most recent analysts' downgrades at MarketBeat.com right arrow


Analysts' New Coverage
  • Amphastar Pharmaceuticals (NASDAQ:AMPH) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $60.00 price target on the stock. This represents a 28.2% upside from the current price of $46.80.
  • Array Technologies (NASDAQ:ARRY) is now covered by analysts at KeyCorp. They set a "sector weight" rating on the stock.The current price is $13.27.
  • TopBuild (NYSE:BLD) is now covered by analysts at DA Davidson. They set a "buy" rating and a $470.00 price target on the stock. This represents a 15.8% upside from the current price of $405.92.
  • Installed Building Products (NYSE:IBP) is now covered by analysts at DA Davidson. They set a "buy" rating and a $275.00 price target on the stock. This represents a 15.1% upside from the current price of $239.01.
  • Metagenomi (NASDAQ:MGX) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $25.00 price target on the stock. This represents a 109.2% upside from the current price of $11.95.
  • Metagenomi (NASDAQ:MGX) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $21.00 price target on the stock. This represents a 75.7% upside from the current price of $11.95.
  • Metagenomi (NASDAQ:MGX) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $23.00 price target on the stock. This represents a 92.5% upside from the current price of $11.95.
  • Metagenomi (NASDAQ:MGX) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $16.00 price target on the stock. This represents a 33.9% upside from the current price of $11.95.
  • Metagenomi (NASDAQ:MGX) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $22.00 price target on the stock. This represents a 84.1% upside from the current price of $11.95.
  • Metagenomi (NASDAQ:MGX) is now covered by analysts at TD Cowen. They set an "outperform" rating on the stock.The current price is $11.95.
  • BBB Foods (NYSE:TBBB) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $26.00 price target on the stock. This represents a 22.0% upside from the current price of $21.32.
  • BBB Foods (NYSE:TBBB) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $22.00 price target on the stock. This represents a 3.2% upside from the current price of $21.32.
  • BBB Foods (NYSE:TBBB) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $26.00 price target on the stock. This represents a 22.0% upside from the current price of $21.32.
  • Zealand Pharma A/S (NASDAQ:ZEAL) is now covered by analysts at Berenberg Bank. They set a "buy" rating on the stock.The current price is $17.59.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: Will Crypto Make People Rich Again Starting April, 2024?

No comments:

Post a Comment

This “Wealth Pattern” Predicted Every 1,000% Move

Crypto's FINAL Wealth Moment  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ...